Skip to main content
. 2017 Mar 17;8(33):55600–55612. doi: 10.18632/oncotarget.16340

Table 3. Cox regression analysis for the risk of death among recurrent HNSCC patients.

Univariate Analysis Multivariate Analysis*
Variable HR (95% CI) p value HR (95% CI) p value
Treatment group
(Reference group: CT alone)
 Re-RT alone (2) 1.02 (0.86–1.22) 0.817 1.00 (0.83–1.20) 0.992
 CCRT (3) 0.72 (0.64–0.81) <0.001 0.70 (0.62–0.79) <0.001
 Surgery ± RT/CT (4) 0.37 (0.33–0.41) <0.001 0.37 (0.34–0.42) <.0001
Age ≥ 65 years 1.11 (1.00–1.24) 0.058 1.13 (1.01–1.26) 0.040
Men 1.09 (0.93–1.28) 0.299 1.10 (0.93–1.29) 0.263
CCI score > 6 1.08 (1.07–1.10) <0.001 1.09 (1.07–1.10) <.0001
Clinical stage at first diagnosis 1.31 (1.27–1.36) <0.001 1.24 (1.20–1.29) <.0001
Recurrence-free interval > 1 year 0.65 (0.59–0.71) <0.001 0.69 (0.63–0.76) <.0001

*All above variables were used in multivariate analysis.

Abbreviations: RT, radiotherapy; CT, chemotherapy; CCRT, concurrent chemoradiotherapy; CCI, Charlson comorbidity index; CI, confidence interval; HR, hazard ratio.